Browse the evidence

Current genomic risk scores alone may not lead to superior weight loss.

Practitioners should not rely solely on genomic risk scores for weight loss strategies.

There is a need for multiomicron integration in personalized nutrition.

Practitioners should consider integrating various omics data for more effective personalized nutrition strategies.

Much remains to be done to make PN interventions more effective and equitable.

Efforts should focus on improving the design and implementation of PN interventions to enhance their effectiveness and accessibility.

The MM diet did not reduce fat mass compared to a usual diet (UD) with a mean difference of -11.36 kg.

Practitioners should be cautious in recommending MM diets for fat loss compared to usual diets.

Less than half of primary care visits include some type of physical activity promotion.

Healthcare providers should prioritize physical activity promotion during patient visits.

Different studies report conflicting results regarding the beneficial role of Blautia in obesity.

Practitioners should be aware of the mixed evidence regarding Blautia's role in obesity when considering interventions.

The US Office of Personnel Management requires adequate coverage of FDA-approved antiobesity medications.

Health practitioners should understand the implications of this coverage requirement for their patients.

Expanded insurance coverage for bariatric surgery provides lessons for antiobesity medication coverage.

Understanding these parallels can help advocate for better coverage of antiobesity medications.

206,361 individuals (68.6%) had obesity according to the new definition compared to 128,992 individuals (42.9%) according to the traditional definition.

Practitioners should consider the new definition of obesity when assessing patients.

108,650 individuals (36.1%) had clinical obesity according to the new definition, with prevalence increasing with age.

Age should be considered when evaluating obesity risk in patients.

Collaboration between oncologists and obesity treatment experts is increasingly important.

Healthcare systems should foster interdisciplinary collaboration.

The article proposes measures to strengthen causal inference in dietary trials.

Implementing proposed measures could enhance the reliability of findings in dietary research.

The overall incidence of remissions per 1000 person-years was 10.5.

Practitioners should be aware of the remission rates in this population.

Cardiovascular, renal, and metabolic diseases are leading global causes of death and are associated with substantial morbidity and mortality.

Healthcare providers should prioritize the management of these diseases due to their significant impact on mortality and morbidity.

Chronic treatment of obese insulin-resistant wild-type animals with a long-acting GIPR agonist prevented rosiglitazone-induced weight gain and hyperphagia.

GIPR agonists may be beneficial in managing weight gain and overeating in insulin-resistant conditions.

Dietary patterns intersect with psychosocial vulnerabilities linked to risks of antisocial behavior.

Understanding dietary influences can help address psychosocial issues related to antisocial behavior.

Obesity is a modern epidemic with substantial health and economic impact.

Recognize obesity as a critical public health issue requiring attention.

Utilization of anti-obesity agents is rising in reproductive-age females planning for future pregnancy.

Practitioners should be aware of the increasing use of anti-obesity agents in this population.

The definitive role of assisting weight loss with medication prior to pregnancy remains to be established.

Further research is needed to clarify the role of anti-obesity medications in weight loss for women prior to pregnancy.

There is no definitive evidence of causality between ultra-processed foods and adverse health outcomes.

Practitioners should be cautious in making definitive claims about UPFs and health outcomes.

The authors propose a paradigm for guiding the formulation of UPFs and their selection by consumers.

Food designers and consumers should consider this paradigm to improve UPF choices.

Exploration of variation in responses to interventions can enhance understanding of generalizability of effects.

Practitioners should explore variation in responses to improve the applicability of their findings.

Metabolically healthy individuals experienced lower event rates with increasing body mass index (BMI).

Emphasizing metabolic health may lead to better outcomes even in individuals with higher BMI.

There is a weak positive association between BMI and KIDMED index in the physically active population, which was not statistically significant.

Practitioners should be cautious in interpreting the relationship between BMI and nutritional status.